2020). Some common chromosome aberrations in neuroblastoma, including recurrent distortions such as gain of 17q and loss of 11q, 2p, and 1p, are associated with poor prognosis (Brady et al., 2020).

Neuroblastoma is a challenging and aggressive form of cancer, primarily affecting children, and its nature often leads to confusion. During an episode of Power Athlete Radio with Dr. Judith ...

Essential Pharma has bought fellow UK drugmaker Renaissance Pharma, adding its first development-stage drug candidate, a therapy for hard-to-treat rare cancer neuroblastoma. The takeover of ...

1Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania. 2Division of Hematology-Oncology, Edmond and Lily Safra Children’s ...

Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China ...